Effect of saline perfusion before catheter removal in patients with benign prostatic hyperplasia treated with GreenLight laser photoselective vaporization of the prostate

Abstract

Abstract Purpose: To investigate the effect of saline perfusion before catheter removal in patients with benign prostatic hyperplasia (BPH) treated with GreenLight laser photoselective vaporization of the prostate (PVP). Materials and Methods: Patients (n=200) with BPH treated with PVP were divided into perfusion (n=100) and control (n=100) groups. For the perfusion group, saline (200 mLor the maximum capacity tolerated) was irrigated into the bladder after standardized external urethral disinfection, and the catheter was removed. Catheter removal was routinely performed in the control group. Perioperative adverse events and clinical outcomes were compared between the groups. Results: Patients in the perfusion group exhibited a shorter waiting time [3 (0–4) vs. 15 (8.75–26) min; P < 0.001] and better satisfaction grade [24 (21.75–26) vs. 23 (20–25); P=0.016] of first urination than those in the control group. The perfusion group exhibited lower anxiety levels regarding first urination than the control group [1 (1–2) vs. 1.5 (1–2), respectively; P=0.012]. Urinalysis revealed that the perfusion group had significantly lower white blood cell (WBC) count than the control group on the day [25.5(8–37.75) vs. 43.5(24.0–64.75); P<0.001] and 2 weeks [20.5(11–27) vs 31.0(20–42); P<0.001] after catheter removal. No significant differences in treatment-related adverse events were observed [(perfusion (n=15), control (n=20)]. Conclusion: Saline perfusion before catheter removal in patients with BPH treated with PVP could shorten the waiting time for first urination, improve patient anxiety and satisfaction, and reduce postoperative urinary WBC levels.